| 12/19/2024 | SP | New Issue: Citigroup prices $1.85 million 10.6% autocallable contingent coupon notes on ResMed
|
| 8/6/2024 | SP | New Issue: Barclays sells $2 million autocallable notes on Vertiv, CVS, ResMed, Builders
|
| 4/12/2024 | SP | New Issue: Barclays sells $4.11 million buffered autocallable contingent coupon notes on stocks
|
| 1/31/2024 | SP | New Issue: UBS prices $861,000 trigger autocallable contingent yield notes on three stocks
|
| 6/30/2022 | BK | ResMed closes $1.5 billion restated revolver, $200 million term loan
|
| 9/4/2020 | SP | New Issue: GS Finance sells $830,000 leveraged basket-linked notes on 103 stocks
|
| 6/18/2020 | SP | New Issue: Goldman prices $7.88 million leveraged basket-linked notes on 62 stocks
|
| 7/15/2019 | PV | New Issue: ResMed sells $500 million 3.24% seven-, 3.45% 10-year notes at par
|
| 7/15/2019 | BK | ResMed to pay down revolver via proceeds of 3.24%, 3.45% notes
|
| 12/3/2018 | BK | ResMed to draw on credit facility for Propeller Health purchase
|
| 11/8/2018 | BK | ResMed increases size of revolving credit facility to $1.6 billion
|
| 11/5/2018 | BK | ResMed to use credit facility borrowings to acquire MatrixCare
|
| 4/19/2018 | BK | ResMed closes $800 million restated revolver, $200 million term loan
|
| 1/12/2017 | BK | ResMed expands senior revolving credit facility to $1.3 billion
|
| 4/4/2016 | BK | ResMed obtains $300 million term loan, expands revolver to $1 billion
|
| 2/22/2016 | BK | ResMed expects to get new credit facility for Brightree purchase
|
| 11/5/2013 | BK | ResMed gets $700 million revolver due 2018 at Libor plus 100 bps
|
| 5/1/2013 | BK | ResMed looks to arrange new credit facility by February 2014
|
| 1/26/2012 | BK | ResMed amends credit agreement, increases revolver to $400 million
|
| 10/6/2008 | BK | ResMed gets $50 million term loan D
|
| 3/17/2006 | BK | ResMed gets $75 million amended and restated revolver
|
| 3/6/2006 | CV | ResMed investors convert all 4% convertibles
|
| 1/5/2006 | CV | ResMed calls 4% convertible notes
|
| 8/29/2003 | CV | Fitch cuts PMI convertible to A+
|
| 6/2/2003 | CV | Fitch ups Northrop outlook to positive
|
| 10/30/2002 | CV | ResMed buys back $5 million convertibles
|
| 7/12/2002 | CV | Market Commentary: Market holds firm against dip in stocks as more buyers emerge
|
| 7/9/2002 | CV | Deutsche sees upside in ResMed as a mispriced credit
|
| 11/21/2001 | CV | Fitch rates new Cendant convertible at BBB+
|
